Nasdaq · Healthcare
LifeStance Health Group, Inc. (LFST)
As-reported financials and recent SEC filings for LifeStance Health Group, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.42B
Net income
$9.7M
Net margin
0.7%
Diluted EPS
—
ROE
0.6%
P/E (TTM)
171.3×
Market cap
$3.93B
Debt / equity
0.2×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.42B | $1.25B | $1.06B | $859.5M | $667.5M |
| Gross profit | — | — | — | — | — |
| Operating income | $24.1M | $-31.6M | $-189.1M | $-210.2M | $-286.4M |
| Net income | $9.7M | $-57.4M | $-186.3M | $-215.6M | $-307.2M |
| Diluted EPS | — | — | — | — | — |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
1442026-06-26
View on EDGAR →42026-06-15
View on EDGAR →8-K2026-06-04
View on EDGAR →SCHEDULE 13G/A2026-05-15
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →Go deeper on LFST
Search LifeStance Health Group, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.